Related Content
Search Google Scholar for:
|
|
Science 6 December 1985: Vol. 230. no. 4730, pp. 1157 - 1160 DOI: 10.1126/science.3865369
|
|
Articles
Science, Vol 230, Issue 4730, 1157-1160
Copyright © 1985 by American Association for the Advancement of Science
A transgenic mouse model of the chronic hepatitis B surface antigen carrier state
FV Chisari,
CA Pinkert,
DR Milich,
P Filippi,
A McLachlan,
RD Palmiter,
and
RL Brinster
In an attempt to establish a model of the healthy carrier state in hepatitis B virus (HBV) infections, transgenic mice expressing HBV genes were produced. Fertilized one-cell eggs were microinjected with subgenomic fragments of HBV DNA containing the coding regions for the HBV surface antigen (HBsAg) and pre-S and X antigens. Either the normal (HBV) or metallothionein promoters were used to obtain expression of the HBV genes. There was no evidence of viral replication or tissue pathology. The integrated HBV DNA sequences were inherited in a normal Mendelian fashion. Three of 16 transgenic mice expressed HBV-encoded gene products to which they were immunologically tolerant. Expression was not tissue specific and may be influenced by the genomic integration site and cellular factors. Both HBsAg and pre-S antigen were detectable within the cytoplasm of hepatocytes and renal tubular epithelial cells. High serum concentrations of HBsAg were detectable and the secreted product appeared authentic as judged by mean density, morphology, mean particle diameter, polypeptide composition, and antigenicity. The absence of tissue pathology in these immunologically tolerant animals supports the hypothesis that cellular injury under these conditions is not a direct consequence of expression of the pre-S or HBs regions of the HBV genome.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Elimination of Immunodominant Epitopes from Multispecific DNA-Based Vaccines Allows Induction of CD8 T Cells That Have a Striking Antiviral Potential.
- P. Riedl, A. Wieland, K. Lamberth, S. Buus, F. Lemonnier, K. Reifenberg, J. Reimann, and R. Schirmbeck (2009)
J. Immunol.
183, 370-380
| Abstract »
| Full Text »
| PDF »
- Separate Origins of Hepatitis B Virus Surface Antigen-Negative Foci and Hepatocellular Carcinomas in Transgenic HBsAg (alb/psx) Mice.
- D. R. Crawford, S. Ostrowski, D. Vakharia, Z. Ilic, and S. Sell (2006)
Am. J. Pathol.
169, 223-232
| Abstract »
| Full Text »
| PDF »
- Distinct, Cross-Reactive Epitope Specificities of CD8 T Cell Responses Are Induced by Natural Hepatitis B Surface Antigen Variants of Different Hepatitis B Virus Genotypes.
- P. Riedl, A. Bertoletti, R. Lopes, F. Lemonnier, J. Reimann, and R. Schirmbeck (2006)
J. Immunol.
176, 4003-4011
| Abstract »
| Full Text »
| PDF »
- Stealth and Cunning: Hepatitis B and Hepatitis C Viruses.
- S. F. Wieland and F. V. Chisari (2005)
J. Virol.
79, 9369-9380
| Full Text »
| PDF »
- High Prevalence of Hepatitis B Virus Pre-S Mutant in Countries Where It Is Endemic and Its Relationship with Genotype and Chronicity.
- T. T.-T. Huy, H. Ushijima, K. M. Win, P. Luengrojanakul, P. K. Shrestha, Z.-H. Zhong, A. V. Smirnov, T. C. Taltavull, T. Sata, and K. Abe (2003)
J. Clin. Microbiol.
41, 5449-5455
| Abstract »
| Full Text »
| PDF »
- Molecular Characterization of the Human La Protein{middle dot}Hepatitis B Virus RNA.B Interaction in Vitro.
- S. Horke, K. Reumann, A. Rang, and T. Heise (2002)
J. Biol. Chem.
277, 34949-34958
| Abstract »
| Full Text »
| PDF »
- Characterization of Nuclear RNases That Cleave Hepatitis B Virus RNA near the La Protein Binding Site.
- T. Heise, L. G. Guidotti, and F. V. Chisari (2001)
J. Virol.
75, 6874-6883
| Abstract »
| Full Text »
- Viruses, Immunity, and Cancer: Lessons from Hepatitis B.
- F. V. Chisari (2000)
Am. J. Pathol.
156, 1117-1132
| Full Text »
| PDF »
- La Autoantigen Specifically Recognizes a Predicted Stem-Loop in Hepatitis B Virus RNA.
- T. Heise, L. G. Guidotti, and F. V. Chisari (1999)
J. Virol.
73, 5767-5776
| Abstract »
| Full Text »
- Hepatitis B Virus RNA-Binding Proteins Associated with Cytokine-Induced Clearance of Viral RNA from the Liver of Transgenic Mice.
- T. Heise, L. G. Guidotti, V. J. Cavanaugh, and F. V. Chisari (1999)
J. Virol.
73, 474-481
| Abstract »
| Full Text »
| PDF »
- Dendritic Cell Immunization Breaks Cytotoxic T Lymphocyte Tolerance in Hepatitis B Virus Transgenic Mice.
- Y. Shimizu, L. G. Guidotti, P. Fowler, and F. V. Chisari (1998)
J. Immunol.
161, 4520-4529
| Abstract »
| Full Text »
| PDF »
- Immune Pathogenesis of Hepatocellular Carcinoma.
- Y. Nakamoto, L. G. Guidotti, C. V. Kuhlen, P. Fowler, and F. V. Chisari (1998)
J. Exp. Med.
188, 341-350
| Abstract »
| Full Text »
| PDF »
- Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice.
- T Moriyama, S Guilhot, K Klopchin, B Moss, C. Pinkert, R. Palmiter, R. Brinster, O Kanagawa, and F. Chisari (1990)
Science
248, 361-364
| Abstract »
| PDF »
- Transgenic animals.
- R Jaenisch (1988)
Science
240, 1468-1474
| Abstract »
| PDF »
- Transcriptional Regulation of the TFIIH Transcription Repair Components XPB and XPD by the Hepatitis B Virus x Protein in Liver Cells and Transgenic Liver Tissue.
- I. Jaitovich-Groisman, N. Benlimame, B. L. Slagle, M. H. Perez, L. Alpert, D. J. Song, N. Fotouhi-Ardakani, J. Galipeau, and M. A. Alaoui-Jamali (2001)
J. Biol. Chem.
276, 14124-14132
| Abstract »
| Full Text »
| PDF »
|
|